Ligand Pharmaceuticals
LGND
#3340
Rank
C$5.73 B
Marketcap
C$287.75
Share price
-0.70%
Change (1 day)
89.45%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): C$88.66 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are C$0.25 Billion. In 2024 the company made an earning of C$7.62 Million a decrease over its 2023 earnings that were of C$88.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$88.66 M1063.07%
2024 C$7.62 M-91.37%
2023 C$88.33 M-7.59%
2022 C$95.58 M4%
2021 C$91.91 M296.42%
2020 C$23.18 M-97.97%
2019 C$1.14 B275.62%
2018 C$0.30 B237.48%
2017 C$90.18 M49.05%
2016 C$60.5 M55.41%
2015 C$38.93 M36.87%
2014 C$28.44 M29.59%
2013 C$21.94 M1309.35%
2012 C$1.55 M-43.97%
2011 C$2.77 M-113.19%
2010 -C$21.08 Million59.86%
2009 -C$13.19 Million-61.33%
2008 -C$34.1 Million-58.75%
2007 -C$82.65 Million20.52%
2006 -C$68.58 Million81.27%
2005 -C$37.83 Million
2003 -C$26.34 Million-20.6%
2002 -C$33.17 Million4.38%
2001 -C$31.78 Million-48.83%
2000 -C$62.1 Million-19.74%
1999 -C$77.37 Million-19.06%
1998 -C$95.59 Million126.71%
1997 -C$42.17 Million-5.83%
1996 -C$44.78 Million136.23%
1995 -C$18.96 Million-33.97%
1994 -C$28.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.49 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.27 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.90 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.32 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.38 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.71 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.03 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.80 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-C$84.99 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA